Brian David Archbold's most recent trade in Mesa Laboratories, Inc. was a trade of 844 Restricted Stock Units - 7 done . Disclosure was reported to the exchange on June 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2025 | 844 | 844 | - | - | Restricted Stock Units - 7 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.82 per share. | 21 Jun 2025 | 844 | 2,792 (0%) | 0% | 95.8 | 80,872 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.82 per share. | 21 Jun 2025 | 385 | 2,407 (0%) | 0% | 95.8 | 36,891 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 2,556 | 4,960 | - | - | Restricted Stock Units - 8 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 92.99 per share. | 18 Jun 2025 | 2,556 | 3,114 (0%) | 0% | 93.0 | 237,682 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 18 Jun 2025 | 1,166 | 1,948 (0%) | 0% | 93.0 | 108,426 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2025 | 7,346 | 7,346 | - | - | Restricted Stock Units - 9 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 535 | 535 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 535 | 0 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 495 | 1,030 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Sale of securities on an exchange or to another person at price $ 97.12 per share. | 15 Jun 2025 | 472 | 558 (0%) | 0% | 97.1 | 45,840 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | 10 Jun 2025 | 2,129 | 12,567 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 13 Sep 2024 | 1,499 | 0 (0%) | 0% | 125 | 187,375 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 845 | 1,688 | - | - | Restricted Stock Units - 7 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 845 | 1,885 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 133.69 per share. | 01 Sep 2024 | 386 | 1,499 (0%) | 0% | 133.7 | 51,604 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 7,516 | 7,516 | - | - | Restricted Stock Units - 8 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 889 | 1,447 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 535 | 535 | - | - | Restricted Stock Units 6 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.60 per share. | 14 Jun 2024 | 407 | 1,040 (0%) | 0% | 91.6 | 37,281 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 354 | 0 | - | - | Restricted Stock Units 4 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | 02 Apr 2024 | 420 | 14,696 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | 08 Jan 2024 | 290 | 15,116 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Archbold Brian David | SVP Operations | Sale of securities on an exchange or to another person at price $ 112.36 per share. | 15 Dec 2023 | 1,500 | 558 (0%) | 0% | 112.4 | 168,540 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 4,579 | 15,406 | - | - | Non Qualified Stock Options | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 612 | 2,247 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 267 | 1,070 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.55 per share. | 16 Jun 2023 | 189 | 2,058 (0%) | 0% | 135.6 | 25,619 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 177 | 354 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 133 | 0 | - | - | Restricted Stock Units - 2 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 35 | 0 | - | - | Restricted Stock Units - 1 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 614 | 1,918 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.45 per share. | 15 Jun 2023 | 283 | 1,635 (0%) | 0% | 134.4 | 38,049 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 267 | 1,337 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 178 | 531 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 134 | 133 | - | - | Restricted Stock Units - 2 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 35 | 35 | - | - | Restricted Stock Units - 1 | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 546 | 0 | - | - | Restricted Stock Unit - 5 | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 546 | 1,359 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 178.42 per share. | 01 Sep 2022 | 412 | 1,304 (0%) | 0% | 178.4 | 73,509 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | VP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 357 | 1,716 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 357 | 709 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 868 | 1,205 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Sale of securities on an exchange or to another person at price $ 188.22 per share. | 17 Jun 2022 | 392 | 813 (0%) | 0% | 188.2 | 73,784 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 338 | 492 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 268 | 267 | - | - | Restricted Stock Units - 2 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.57 per share. | 17 Jun 2022 | 155 | 337 (0%) | 0% | 185.6 | 28,763 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 70 | 70 | - | - | Restricted Stock Units - 1 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 3,852 | 10,827 | - | - | Non Qualified Stock Option | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,604 | 1,604 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Sale of securities on an exchange or to another person at price $ 325.02 per share. | 14 Dec 2021 | 1,659 | 154 (0%) | 0% | 325.0 | 539,208 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | 14 Dec 2021 | 917 | 6,975 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 226.72 per share. | 14 Dec 2021 | 917 | 1,813 (0%) | 0% | 226.7 | 207,902 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | 14 Dec 2021 | 532 | 7,892 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 203.54 per share. | 14 Dec 2021 | 532 | 896 (0%) | 0% | 203.5 | 108,283 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.40 per share. | 14 Dec 2021 | 210 | 364 (0%) | 0% | 142.4 | 29,904 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Operations | 14 Dec 2021 | 210 | 8,424 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 3,421 | 8,634 | - | - | Non Qualified Stock Options | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,066 | 1,066 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 546 | 546 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Sale of securities on an exchange or to another person at price $ 280.03 per share. | 09 Aug 2021 | 639 | 154 (0%) | 0% | 280.0 | 178,939 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Sale of securities on an exchange or to another person at price $ 256.56 per share. | 17 Jun 2021 | 400 | 793 (0%) | 0% | 256.6 | 102,624 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 1,960 | 2,529 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Sale of securities on an exchange or to another person at price $ 255.67 per share. | 15 Jun 2021 | 921 | 1,608 (0%) | 0% | 255.7 | 235,472 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 419 | 0 | - | - | Restricted Stock Unit - 3 | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 419 | 920 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Sale of securities on an exchange or to another person at price $ 260.14 per share. | 15 Jun 2021 | 415 | 1,193 (0%) | 0% | 260.1 | 107,958 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.30 per share. | 15 Jun 2021 | 351 | 569 (0%) | 0% | 263.3 | 92,418 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 277 | 535 | - | - | Restricted Stock Unit - 2 | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 277 | 501 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 70 | 140 | - | - | Restricted Stock Units - 1 | |
| Mesa Laboratories, Inc. | Brian David Archbold | VP of Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 70 | 224 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Sale of securities on an exchange or to another person at price $ 271.78 per share. | 10 Mar 2021 | 223 | 154 (0%) | 0% | 271.8 | 60,607 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | 10 Mar 2021 | 145 | 5,213 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.10 per share. | 10 Mar 2021 | 145 | 377 (0%) | 0% | 129.1 | 18,720 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Sale of securities on an exchange or to another person at price $ 272.11 per share. | 09 Nov 2020 | 533 | 232 (0%) | 0% | 272.1 | 145,035 | Common Stock |
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | 09 Nov 2020 | 533 | 5,358 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Brian David Archbold | SVP Continuous Improvement | Exercise or conversion of derivative security received from the company (such as an option) at price $ 203.54 per share. | 09 Nov 2020 | 533 | 765 (0%) | 0% | 203.5 | 108,487 | Common Stock |